The Challenge: Overcoming the Limitations of Myocardial BOLD MRI
Myocardial Blood Oxygen Level Dependent (BOLD) MRI represents a significant goal in cardiac imaging, offering a non-invasive way to assess heart muscle perfusion without the need for exogenous contrast agents. However, its clinical adoption at high field strengths (3T) has been hindered by poor spatial coverage, sensitivity to heart rate variability, and artifacts caused by respiratory motion and magnetic field inhomogeneities.
A High-Efficiency 3D Approach
To address these challenges, researchers developed a novel 3D $T_2$ mapping technique designed for near 100% imaging efficiency. Unlike traditional gated sequences that wait for specific points in the cardiac cycle, this method is heart-rate independent and allows for free-breathing, significantly improving patient comfort and scan reliability.
The technique was validated using a simultaneous PET/MR system in a canine model ($n=11$). This setup allowed for direct comparison between the MRI-derived $T_2$ maps and $^{13}$N-ammonia PET—the clinical gold standard for measuring myocardial blood flow (MBF). The study included both healthy subjects and those with induced LAD artery stenosis to test the method's diagnostic capabilities under rest and adenosine-induced stress.
Key Results and Validation
The study demonstrated that $T_2$ relaxation times serve as a sensitive marker for the BOLD effect. In healthy subjects, myocardial $T_2$ values increased significantly from rest ($38.5 \pm 1.0$ ms) to stress ($44.4 \pm 3.1$ ms), correlating with a 2.5-fold increase in blood flow confirmed by PET.
A critical finding was the high correlation ($R^2 = 0.67$) between the MRI-based BOLD response and the PET-derived Perfusion Reserve. This suggests that fast, 3D $T_2$ mapping can effectively serve as a surrogate for more expensive and radioactive PET scans.
In subjects with arterial stenosis, the technique successfully identified perfusion defects. The Myocardial BOLD Response (MBOLDR) was significantly lower in affected regions ($1.00 \pm 0.03$) compared to remote, healthy regions ($1.09 \pm 0.04$), matching the patterns observed in the PET data.
Moving Toward Clinical Application
By achieving whole-heart coverage in under three minutes without requiring breath-holds or contrast, this technique represents a major step toward viable clinical BOLD MRI. While this canine study provides strong proof-of-concept, future work must validate these findings in human patients to account for differences in heart size and respiratory patterns. If successful, this "fast and free-breathing" approach could revolutionize routine cardiac care by providing a safer, more efficient alternative to contrast-enhanced exams.
Summary updated